Reddit Posts
Mentions
Daily reminder $LENZ is continuing to gain traction. Still a great entry point. Fidelity entered at 15% ownership of common shares this week. CFO purchased $50,000 worth of shares Friday. Consensus price target of many firms is $54/share. estimated revenue for 2026 is $54 million(which I think they will beat significantly if the eye drops gain strong traction). Sarah Jessica Parker to be the face of direct to consumer campaign starting in Jan 2026. They only need to capture 1% of US target demographic of 126,000,000 people to generate $1 billion annually.
$LENZ - what a manipulation, despite decent earnings.. just so insiders can slowly load up at low price. Fidelity investments bought too!
I stand corrected. Typed in LENZ and for some reason it sent me to the Tenpoint therapeutics website instead. Thanks.
my dad did the LENZ trial, I believe he did all 3 phases, and at the same time did 2 other trials for similar products from other companies and when LENZ was the only one that worked he literally went all in on the stock in April. we are big believers in this product! strapped with LEAPS and 1000+ shares! fingers crossed
LENZ - eye drops that replace reading glasses. they actually work. just went commercial. license deals with china and canada. huge market opportunity to tap into. my dad uses the product and raves about it. short interest currently 42% - very small float. good entry price rn and i like the stock - do your own DD
NEW SCHEDULE 13G Showing Fidelity has a 15% ownership stake in $LENZ LETS GOOO BABY THE BIG BOYS BELIEVIN
$LENZ the truth must be set FREEEEEEE
$LENZ rise to the top has begun. Still an excellent entry point for you. I will keep preaching until someone listens. I believe the market dip is scaring short sellers into closing positions due to fear of potential margin calls. Stock is 🩳. 40% still. But the numbers don’t lie, we got potential here. 396 shares $38 avg share price 🥴(thesis has me holding till EOY 2026 unless if tangible negative news comes out)
Daily Reminder $LENZ has huge potential. Trend is fighting to inverse the massive short positions the non believers have.
LEND ME YEAR EARS BROTHERS AND SISTERS AND I WILL GIVE YOU MY VISION HAVE I BEEN WRONG IN THE PAST??? FUCK YEAH WILL I BE WRONG IN THE FUTURE??? FUCK YEAH HOWEVER THIS TIME IM MAYBE, POSSIBLY GOT IT RIGHT AND EARLY TO THE PARTY $LENZ 396 Shares $33 per share GUH
Ridicule me all you want. $LENZ still has the potential to be a 1 Billion dollar top line revenue generating company if they only capture 1% of their 126,000,000 US target demographic.
Am I regarded? Yes, I am regarded for my position in $LENZ. However we are all regarded, we are not here to full port 100% VT and brag about it. We are here to put $10k on something wild and hit the fucking lotto. Be kind. Love you all. Hope you all make it big so we can change our lives and the lives of the ones we love. Yours Truly, -SCO
$LENZ Q3 Highlights & Risks The Good: - 90% awareness of Eye Care Professionals - 5,000 scripts (most happened in final two weeks of Oct) by 2,500 ECPs 40% of which have done repeated scripts. - Sarah Jessica Parker direct to consumer campaign starts in Jan 2026. - Enough cash runway for 2-3 years of current operations. - Non-ECP Doctors want to be able to prescribe. - Side effects and concerns with prior failed drug company Vuity are not being experienced. The Bad: - Overcoming the negative stigma of Vuity(prior company first to market with drug that had terrible side effects). - 5,000 scripts is a good start but nowhere near enough. To reach 1 billion in revenue we need to trend towards 1 million scripts per year. If they double scripts each month and hats achieved in 10 months. - Increase in SG&A expenses - gotta spend money to make money. Q3 obviously had one off expenses so SG&A moving forward will be slightly lower and R&D will continue to tapper down. The Other: - I have been anecdotally polling individuals that have used the drops to understand side effects and if they are happy or not and will continue using. - 70-80% are happy with the experience. - 50% have explicitly stated they will continue to routinely use the drops. I remain optimistic and will continue to add to my position at these prices. Wish me luck regards. -SCO
Adding more to $LENZ Good earnings report on expansion plans with new drug that is FDA approved Public traction is beginning to grow stronger My avg price is $32, great entry point for those that done want bags like mine. Stock is shorted 40% as well. Oh and Sarah Jessica Parker is the spokesperson for 2026 DTC campaign 😂
$LENZ the shorts on Lenz are pounding my asshole hard. Good thing I’m willing to watch it go to zero lol
$LENZ had a phenomenal Q3 earnings report Side effects minimal ECD awareness 90% 5,000 scripts in 4 weeks 50% of witch were multiple scripts from ECDs. Direct to consumer campaign starts in Jan 2026 with Sarah Jessica Parker as the face of the campaign. A focus on digital advertisements Facebook, instagram, Pinterest and more. Maintain a very strong cash position of $320 million and further improved health of an already healthy balance sheet. Over 12 months of runway with cash on hand. Multiple licensing deals with up front cash and continued licensing revenues in the future. We should have a good vision for the future by end of Q2 2026. Shorts are forcing it down by shorting 40% of the stock, sharing the opportunity to enter at a price we won’t see again if they take their shorts off the neck of the stock.
Daily charts of AMD, CIFR, INTC, LENZ, MARA, SNDK.. and many others are showing **LARGE** green candles.. It's just a fake shakeout 👏 to trigger stop loss for smaller players, so the whales can scoop up profits after earnings. LoL, so obvious!
Do I have significant unrealized losses on $LENZ currently? Yes Has my thesis changed? No $LENZ needs to only capture 0.08% of their target audience to bring in $1 billion a year in revenue. That is the thesis. What is public opinion on the drops? Mixed, however not for the failures of other drops that have tried to achieve the same. Side effects are significantly lower than other companies that tried to create a product like VIZZ. I continue to hold until that public perception changes meaningfully in the wrong direction. Do with this information as you would like.
Short term: Uber call Mid term: AAPL call thru Xmas (if affordable) Long term: LENZ call leap 2-3yr, FI call leap
great chance to buy LENZ
$LENZ Boomers will love it.
!banbet LENZ to $40 on one month
If $LENZ therapeutics gets 5% of its target 126 million target demographic just 5% that’s over 6 billion in revenue. Food for thought.
$LENZ short interest at 40% now 😬 Get in before it’s cool 😎 ^itmightneverbecooloreverrecievepropertractionthisisnotfinancialadvice
$LENZ Therapeutics. Check my DD if you want more understanding. Short interest is 40% right now.
$LENZ Therapeutics. - multiple price increases by rating firms - good public perception from people posting online - Blackrock opens $80 million dollar stake at $45 a share - 40% short interest, shorts are doubling down on their bet due to failed drug Vuity in the past. Kenzie Therapeutics has already shown in testimony that the side effects that lead to Vuity failure are not seen in VIZZ. (Muscular contraction around the eyes leading to headache) I added more today and have 250 shares with avg price of $36 Primed for a big move but needs more buy-in.
$LENZ new formula eye drop for improved vision continues to impress as October is the first month of distribution for the public. https://www.fox26houston.com/news/vizz-fda-approved-eye-drop-regain-near-vision.amp
Do you need to hold your mobile far off to read this text? Well, if you don't, quite likely at least a few of your uncles / parents or older brother or sister does. At least one of them will be using Vizz eye drops next month, instead of those annoying near vision glasses. Vizz recently got FDA approval and is made by **$ LENZ** That's what you'd leap on 😉
Now is the time. $LENZ has so much damn potential. I will keep sharing this till my last day on this earth. https://www.reddit.com/r/investing/s/GolVhgqWBW
$LENZ I’ve been preaching for 2 months now. Analysts all raising price targets Blackrock opened a $80 million dollar position High as fuck short interest at 30% Eye drops being well received Get in now before the launch 🚀
*If you need to hold your mobile far off to read this, then* $LENZ
$LENZ all day baby, market gave you a beautiful entry point.
$LENZ great price point to enter. Cries in high cost basis. Nothing on thesis has changed, drops are being well received by consumers which is the highest risk point at the moment. Many firms increasing price points and weights. Good stuff here folks.
$LENZ Fake dump to create entry for big boys. Marketing starts THIS MONTH and dumped to $32 from $50 the past 2 weeks caaaaaaaauuuuuussssse??????? Fake! 👿
^^If you need to hold your mobile far off to read this properly, you need to consider^^ #$LENZ huge market awaiting those eye drops!
Picked up some IREN and LENZ 🤤
Shorts on $LENZ trying to push it down cuz they know they’re fuuuuuuuucked. Short interest 20%
$LENZ huge ceiling, drug is being well received by current reviews. $40 to $500 in 2 years. Send it!
Anyone else here in $LENZ? It feels so lonely being early to the party.
$LENZ Pump! People love the VIZZ drops! LETS GO!
$LENZ all day, till I’m rich.
General anecdotal feedback on VIZZ eyedrops is good so far! $LENZ is a steal at its current price. This thing could blow up and fast especially if public perception continues to be positive.
ok im gonna let a few of you in on an early one.. $LENZ. been in since $27, my dad was a trial patient and was chompin at the bit for this stuff ever since the trial. it is an eye drop that replaces reading glasses and it works amazing. currently transitioning from R&D to commercialization. nov will be first earnings since the transition. product VIZZ was launched this month. do your own DD, but i see $70 easy by EOY. got about 1100 shares, plus a few leaps, some laddered shorter term calls, and wildly bullish on this company.
It’s getting lonely being the only person excited about $LENZ 😭
$LENZ now before 🚀 if Q4 distribution numbers smash and public perception and usage of VIZZ is strong it’s liftoff time.
$LENZ Q4 numbers could be the next catalyst since they are in their distribution and scaling phase. 💪🏽
$LENZ all day every day. 💪🏽
$LENZ over $50 in Pre-Market LETS FUCKING GOOOO FUCK YOU MODS FOR CONTINUALLY DELETING MY DD YOU FUCKING NERDS
Has anyone taken my recommendation on $LENZ yet?
LENZ is one of the best buys out there. Eye care company that is the first of its kind. 8 hour reading glasses with eye drops. It just got fda approval and sales begin in q4. If you arent seeing the upside on this one idk what you are seeing.
$LENZ taking off 🛫 Lots of growth potential in an arena with zero competition. If their drug is well received a stock price of $200-$300 in 2-3 years is easy.
$LENZ if you want something fun new and exiting that’s not AI Uranium of the Mag 7 They start distributing the drug VIZZ this week.
$LENZ MOVING UP Too bad garbage mods kept trashing my DD on it because they have tiny private parts 🤭
$GOOG - Greed always wins $UNH - Greed always wins $LENZ - Now I can see clearly why greed always wins $LULU - I won’t give up on you Becky
Dude only talks about $LENZ
$LENZ I get that it can come off as a pump but I like it and it’s a solid speculative play. So I’ve been working on getting more eyes on it to see what people think. I think my DD post on r/investing might still be up.
I tried Vuity for fun and dosed a bunch of people at the office. Headaches and nausea were common. Quality of vision took a small hit, and positive effects didn’t last long. Too many strikes. I’ll try the new one. If it works and is tolerated they’ll probably sell a fair bit. Then I’d buy LENZ
Getting optometrists on board is going to be the struggle, since it's gonna have to be more organic than manufactured. LENZ probably doesn't have the money for an army of pharma reps to bribe optos with dinner to push it, and until they're far enough into production for surpluses they're not likely to offer trial samples. But, this is a generally cool product, just about everyone is impressed when they hear that the vision-correcting eyedrops is a real thing. As VIZZ gains more exposure it'll hopefully hype itself, and as you pointed out, it's only gotta convert a small portion of that hype into prescriptions to make big bucks.
$LENZ speculative biotech with large upside. FDA approval achieved now we wait to see if they capture a large enough market demographic.
Said it before, I’ll say it again. $LENZ vision of the future is closer than you think and it’s crystal clear.
$LENZ has multi-bagger potential over the next 12-24 months. You heard it here first Ladies
Check out my $LENZ post I need more feedback on the viability of my DD.
I like LENZ Therapeutics for speculative high growth potential. Check my post history for more detail on it. Essentially they are first to market for an Eye drop that helps reduce farsightedness for 10 hours a day. They have FDA approval and are gearing up for the distribution phase.
Someone else look into $LENZ with me and tell me I’m not crazy.
True to my flair I think I found a gem. $LENZ Check my post, looking for some critical feedback on if I’ve got rose tinted glasses or if this is as much of a slam dunk as it seems. From what I can tell the major challenge would be, how quickly could pharma copies of VIZZ show up?
$LENZ Do your research. Sleeping giant.
What are yalls thoughts on $LENZ?
One of my new favorites is LENZ - they got approved for eyedrops to fix near sight - that is a HUGE market. And it’s a sleeper. Put away close to 1K profit playing it cautiously, and still have some from 27 - now at 42
Small-cap pharma stocks have been absolute fucking duds lately. LENZ and TNXP already burned me this month off of blockbuster drug approvals.
With the new wild west FDA, small-cap pharmas are absolutely killing it on big new treatment approvals but getting no stock pop from it in this shit-ass meme market. LENZ and TNXP are two examples. Maybe it's because these companies are picking some stupid fucking names lmao
u/moorhound >Heads up on an actual not piece of shit corrupt ass play: >LENZ just got FDA approval for VIZZ, a once-daily eyedrop that fixes vision for presbyopia (100m+ US cases) without glasses or contacts. Estimated time to market is in 3 months. Stupid naming conventions aside, this is some sci Fi medical shit. >Of course the bastards released the info after trading hours, but LENZ already popped 8% in AH and will probably run like a adderalled horse on Monday. Thoughts on LENZ? It closed AH Friday at $37, trading PM Monday morning at $40-$45. Going steadily down since then to $36 range. Are you still long.
bought 1000x BTAI at 2.91. sold 750 at 5.05. 100 at 5.13 and 100 at 5.37. holding the 50 shares remaining in case it gets crazier. bought 100x LENZ at 31.29. sold 75 at 40.11 and 15 at 39.37. holding 10 for the same reason
thank you for those posts! went in BTAI and LENZ last Monday because of you! 🙌
whoever posted about BTAI and LENZ last weekend. Thank you!
Heads up on an actual not piece of shit corrupt ass play: LENZ just for FDA approval for VIZZ, a once-daily eyedrop that fixes vision for presbyopia (100m+ US cases) without glasses or contacts. Estimated time to market is in 3 months. Of course the bastards released the info after trading hours, but LENZ already popped 8% in AH and will probably run like a adderalled horse on Monday.
Gainers this morning -BioXcel Therapeutics Inc. (BTAI) is up over 42% at $1.86 -4D Molecular Therapeutics, Inc. (FDMT) is up more than 28% at $5.80 -Shuttle Pharmaceuticals Holdings Inc. (SHPH) is up nearly 17% at $4.29 -Fulgent Genetics Inc. (FLGT) is up 16% at $19.99 -Medicinova Inc. (MNOV) is up 13% at $1.50 -LENZ Therapeutics Inc. (LENZ) is up nearly 11% at $32.90 -Alphatec Holdings Inc. (ATEC) is up over 10% at $11.69 -Cytosorbents Corp. (CTSO) is up 9% at $0.93 -Plus Therapeutics Inc. (PSTV) is up nearly 7% at $0.52 -Venus Concept Inc. (VERO) is up over 6% at $2.72
Bit of onfo. I work in the pre-production of advertising campaigns. We recently worked on a major campaign for LENZ and another for SPRY. These are all high $$ advertising campaigns. I've tracked others (Wegovy, ZEP, Ozempic) in the past that we have work on and they all worked out.
Legit , legendary move. Flip that into LENZ, Aug 🔑
I can’t reveal my source. I’m well aware that it’s already popping off but LENZ.
Bought OCGN, KULR and CISS. Bought KULR May .5 calls. Any of you buy GRPH when I posted a few weeks back? Merger went through with LENZ and that shit is going crazy today. I'm regarded and sold it way too soon at 11 :( At least I got the divies, right? :|